Cancer 
        Digest        

A new cost/benefit analysis of an immunotherapy drug that showed significantly longer survival for people with an aggressive form of lung cancer, called small-cell lung cancer, concludes that the treatment might be too expensive to be worth it.

Lung cancer patients who received COVID-19 vaccination survived nearly twice as long as similar patients who did not get the vaccine, a new observational study shows.

A simple injection of a new type of drug may offer new hope for patients whose head an neck cancers returns after chemotherapy and immunotherapy, results of an ongoing early phase clinical trial show.

Clinical results suggest that radiation therapy might help overcome immunotherapy resistance in certain lung cancer patients

Mesothelioma of the left lower lung on X-ray. Image by James Heilman, MD under Creative Commons license on Wikimedia CANCER DIGEST –...

Image credit Mass General Brigham Hospital CANCER DIGEST – July 12, 2025 – Small cell lung cancer patients whose cancer has spread to the...

Study author Federica Pecci, MD of Dana Farber Cancer Institute – photo credit Dana Farber CANCER DIGEST – April 20, 2025 – Cancer...

New Pfizer drug shows effectiveness in treating cancer-related wasting disease or cachexia.

CANCER DIGEST – Feb. 24, 2024 – Patients with non-small cell lung cancer who have not responded to standard therapy achieved better...

CANCER DIGEST -- Oct. 27, 2023 -- Lung cancer patients who underwent immunotherapy before and after surgery had a 32 percent lower risk...